Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-07-20
1992-03-17
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142358, 544114, 544239, 544163, A61K 3150, A61K 31535, C07D23714
Patent
active
050969048
ABSTRACT:
Pyridazinones of the following formula (I): ##STR1## where R.sup.1 -R.sup.4 are a variety of substituents and L is a linking group, a pharmaceutical composition for treating congestive heart failure, novel intermediates, methods for such treatment and processes for preparing compounds of formula (I).
REFERENCES:
patent: 4397854 (1983-08-01), Sircar
patent: 4599333 (1986-07-01), Yasuda et al.
patent: 4608383 (1986-04-01), Wiedemann
patent: 4652563 (1987-03-01), Slater
patent: 4711887 (1987-12-01), Briggs et al.
patent: 4843072 (1989-06-01), Yasuda et al.
Buorger, "Medicinial Chemistry", 2d ed., Interscience, New York, (1960), p. 42.
R. A. Slater, J. Med. Chemistry, vol. 31, No. 2, pp. 345-356 (1988).
W. V. Curran et al., J. Med. Chemistry, vol. 17, No. 3, pp. 273-281 (1974).
Kenakin Terrence P.
Shaffer Joel E.
Wheeler Thomas N.
Daus Donald G.
Glaxo Inc.
Joyner Charles T.
Levy David J.
LandOfFree
Pyridazinones having cardiotonic and beta blocking activities does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridazinones having cardiotonic and beta blocking activities, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridazinones having cardiotonic and beta blocking activities will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1476041